American Renal Associates Holdings Inc (NYSE:ARA) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $6.59 and traded as low as $6.22. American Renal Associates shares last traded at $6.24, with a volume of 37,438 shares traded.
ARA has been the topic of a number of research analyst reports. Zacks Investment Research lowered American Renal Associates from a “buy” rating to a “hold” rating in a research report on Tuesday, June 2nd. ValuEngine downgraded American Renal Associates from a “buy” rating to a “hold” rating in a report on Wednesday, August 12th. Five research analysts have rated the stock with a hold rating, The company presently has an average rating of “Hold” and an average price target of $8.25.
The company has a quick ratio of 1.00, a current ratio of 1.02 and a debt-to-equity ratio of 8.51. The firm has a market capitalization of $223.57 million, a P/E ratio of -18.91 and a beta of 1.58. The stock has a fifty day moving average of $6.59 and a 200-day moving average of $6.77.
American Renal Associates (NYSE:ARA) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.14. The business had revenue of $205.15 million during the quarter, compared to the consensus estimate of $224.89 million. American Renal Associates had a positive return on equity of 13.79% and a negative net margin of 1.12%. Sell-side analysts predict that American Renal Associates Holdings Inc will post -0.16 EPS for the current fiscal year.
A number of hedge funds have recently bought and sold shares of the business. Jane Street Group LLC bought a new position in American Renal Associates in the second quarter valued at approximately $174,000. Bank of America Corp DE lifted its position in shares of American Renal Associates by 13.6% in the second quarter. Bank of America Corp DE now owns 43,124 shares of the company’s stock valued at $282,000 after buying an additional 5,154 shares during the last quarter. Globeflex Capital L P acquired a new stake in shares of American Renal Associates in the second quarter valued at approximately $637,000. Seizert Capital Partners LLC acquired a new stake in shares of American Renal Associates in the second quarter valued at approximately $148,000. Finally, Strs Ohio lifted its position in shares of American Renal Associates by 72.7% in the second quarter. Strs Ohio now owns 79,800 shares of the company’s stock valued at $520,000 after buying an additional 33,600 shares during the last quarter. Hedge funds and other institutional investors own 78.93% of the company’s stock.
About American Renal Associates (NYSE:ARA)
American Renal Associates Holdings, Inc operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease.
Further Reading: Street Name
Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.